Literature DB >> 28537249

Airway T cells protect against RSV infection in the absence of antibody.

E Kinnear1, L Lambert1, J U McDonald1, H M Cheeseman1, L J Caproni2, J S Tregoning1.   

Abstract

Tissue resident memory T (Trm) cells act as sentinels and early responders to infection. Respiratory syncytial virus (RSV)-specific Trm cells have been detected in the lungs after human RSV infection, but whether they have a protective role is unknown. To dissect the protective function of Trm cells, BALB/c mice were infected with RSV; infected mice developed antigen-specific CD8+ Trm cells (CD103+/CD69+) in the lungs and airways. Intranasally transferring cells from the airways of previously infected animals to naïve animals reduced weight loss on infection in the recipient mice. Transfer of airway CD8 cells led to reduced disease and viral load and increased interferon-γ in the airways of recipient mice, while CD4 transfer reduced tumor necrosis factor-α in the airways. Because DNA vaccines induce a systemic T-cell response, we compared vaccination with infection for the effect of memory CD8 cells generated in different compartments. Intramuscular DNA immunization induced RSV-specific CD8 T cells, but they were immunopathogenic and not protective. Notably, there was a marked difference in the induction of Trm cells; infection but not immunization induced antigen-specific Trm cells in a range of tissues. These findings demonstrate a protective role for airway CD8 against RSV and support the need for vaccines to induce antigen-specific airway cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28537249     DOI: 10.1038/mi.2017.46

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  37 in total

1.  Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen.

Authors:  Silvia Ariotti; Joost B Beltman; Grzegorz Chodaczek; Mirjam E Hoekstra; Anna E van Beek; Raquel Gomez-Eerland; Laila Ritsma; Jacco van Rheenen; Athanasius F M Marée; Tomasz Zal; Rob J de Boer; John B A G Haanen; Ton N Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

2.  Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection.

Authors:  L M Wakim; J Smith; I Caminschi; M H Lahoud; J A Villadangos
Journal:  Mucosal Immunol       Date:  2015-01-14       Impact factor: 7.313

3.  Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.

Authors:  Ryan F Russell; Jacqueline U McDonald; Maria Ivanova; Ziyun Zhong; Alexander Bukreyev; John S Tregoning
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

4.  Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.

Authors:  Pedro A Piedra; Alan M Jewell; Stanley G Cron; Robert L Atmar; W Paul Glezen
Journal:  Vaccine       Date:  2003-07-28       Impact factor: 3.641

5.  The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice.

Authors:  John S Tregoning; Yuko Yamaguchi; James Harker; Belinda Wang; Peter J M Openshaw
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

6.  The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin.

Authors:  Laura K Mackay; Azad Rahimpour; Joel Z Ma; Nicholas Collins; Angus T Stock; Ming-Li Hafon; Javier Vega-Ramos; Pilar Lauzurica; Scott N Mueller; Tijana Stefanovic; David C Tscharke; William R Heath; Michael Inouye; Francis R Carbone; Thomas Gebhardt
Journal:  Nat Immunol       Date:  2013-10-27       Impact factor: 25.606

7.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

8.  Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity.

Authors:  M Bivas-Benita; G O Gillard; L Bar; K A White; R J Webby; A-H Hovav; N L Letvin
Journal:  Mucosal Immunol       Date:  2012-07-18       Impact factor: 7.313

9.  Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.

Authors:  Hannah M Cheeseman; Ann M Carias; Abbey B Evans; Natalia J Olejniczak; Paul Ziprin; Deborah F L King; Thomas J Hope; Robin J Shattock
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

10.  Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.

Authors:  K M Morabito; T R Ruckwardt; A J Redwood; S M Moin; D A Price; B S Graham
Journal:  Mucosal Immunol       Date:  2016-05-25       Impact factor: 7.313

View more
  39 in total

1.  Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells.

Authors:  Frances C Knight; Pavlo Gilchuk; Amrendra Kumar; Kyle W Becker; Sema Sevimli; Max E Jacobson; Naveenchandra Suryadevara; Lihong Wang-Bishop; Kelli L Boyd; James E Crowe; Sebastian Joyce; John T Wilson
Journal:  ACS Nano       Date:  2019-10-04       Impact factor: 15.881

2.  Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence.

Authors:  Miriam F Moffatt; Michael J Cox; John S Tregoning; Helen T Groves; Sophie L Higham
Journal:  mBio       Date:  2020-02-18       Impact factor: 7.867

Review 3.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

Review 4.  Sentinels of the Type 2 Immune Response.

Authors:  Jakob von Moltke; Marion Pepper
Journal:  Trends Immunol       Date:  2017-11-06       Impact factor: 16.687

Review 5.  Tissue-resident innate immunity in the lung.

Authors:  Amanda Ardain; Mohlopheni J Marakalala; Alasdair Leslie
Journal:  Immunology       Date:  2019-11-21       Impact factor: 7.397

Review 6.  Adjuvanted influenza vaccines.

Authors:  John S Tregoning; Ryan F Russell; Ekaterina Kinnear
Journal:  Hum Vaccin Immunother       Date:  2018-01-25       Impact factor: 3.452

7.  Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice.

Authors:  Megan E Schmidt; Antonius G P Oomens; Steven M Varga
Journal:  J Immunol       Date:  2019-04-19       Impact factor: 5.422

Review 8.  Tissue-Resident T Cells and Other Resident Leukocytes.

Authors:  David Masopust; Andrew G Soerens
Journal:  Annu Rev Immunol       Date:  2019-02-06       Impact factor: 28.527

9.  Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.

Authors:  Laura M Stephens; Kathleen A Ross; Kody A Waldstein; Kevin L Legge; Jason S McLellan; Balaji Narasimhan; Steven M Varga
Journal:  J Immunol       Date:  2021-04-07       Impact factor: 5.422

Review 10.  Nanoparticle vaccines against respiratory syncytial virus.

Authors:  Laura M Stephens; Steven M Varga
Journal:  Future Virol       Date:  2020-11-30       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.